Post by
SS1316 on Mar 14, 2023 1:21pm
MRSN Mersana therapeutics
Mersana just had to stop their clinical trials on their cancer drug because someone in their trials died, yet they didn't collapse in price... $500Mil market cap on a clinical stage company. I mean I don't blame the market for not liking this mute, arrogant French Canadian dumpster fire but come on at least we didn't kill anyone.
Comment by
realitycheck4u on Mar 14, 2023 1:28pm
This post has been removed in accordance with Community Policy
Comment by
Trogarzon on Mar 14, 2023 1:43pm
Yes you are wright we are the responsible ones and again they did put it pretty clearly in a non FDA requested PR after teh market close that it did'nt do nothing they taught it would do the day before but stay tune maybe it works anyway. And yes it's all our fault buddy.